To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLC

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)894-896
Number of pages3
JournalJournal of Thoracic Oncology
Volume16
Issue number6
DOIs
StatePublished - Jun 2021

Keywords

  • Antibodies, Monoclonal
  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • ErbB Receptors/genetics
  • Humans
  • Lung Neoplasms/drug therapy

Cite this